We have examined the hypothesis that the release-of tissue type plasminogen activator may play a prominent role in endothelin induced gastric mucosal injury. We determined tissue type plasminogen activator activity in the regional blood sample and the concentration of platelet activating factor in the gastric mucosa after the administration of endothelin-l in a range of 50-500 pmoll kg into the left gastric artery of male Wistar rats. Endothelin-1 increased the tissue type plasminogen activator release and platelet activating factor formation, and induced subsequent gastric mucosal haemorrhagic change in a dose dependent manner. In addition CV-6209, a selective platelet activating factor blocker, attenuated the activation of regional tissue type plasminogen activator and the development of mucosal damage induced by endothelin-1. The results of this study showed that tissue type plasminogen activator activation may play an important role in the pathogenesis of endothelin induced mucosal injury of rat stomach, and suggest that the platelet activating factor may be involved in the process of regional fibrinolytic activation induced by endothelin-1. The aim of this study is to elucidate the effect of endothelin-1 on the tissue type plasminogen activator activation followed by mucosal damage in the rat stomach. In addition we have also investigated the involvement of platelet activating factor in the endothelin induced fibrinolytic activation.
Microcirculatory disturbances of the stomach are thought to be one of the factors contributing to the development of gastric mucosal damages. A previous study has shown that mucosal tissue type plasminogen activator, when released from endothelial cells by platelet activating factor, plays an important role in the process of gastric ulcer formation by inducing macromolecular permeable change in the rat experimental model.' We have also reported that endothelin-1 is synthesised in the endothelial cells of submucosal arterioles in the early phase of the development of gastric mucosal injury in the same experimental model.2 In addition, it was recently reported that endothelin can increase the fibrinolytic activity in vivo and in vitro. 3 These results give rise to the hypothesis that endothelin might increase the tissue type plasminogen activator activity accompanying the gastric mucosal injury. No detailed studies have been carried out, however, on the involvement of endothelin-1 in the fibrinolytic activation during the pathogenesis of gastric mucosal haemorrhagic lesions.
The aim of this study is to elucidate the effect of endothelin-1 on the tissue type plasminogen activator activation followed by mucosal damage in the rat stomach. In addition we have also investigated the involvement of platelet activating factor in the endothelin induced fibrinolytic activation. Figure 2 : Relationship between gastric mucosal lesion and tissue type plasminogen activator (t-PA) activity induced by endothelin-1. The area ofmucosal lesion and the t-PA activity were plotted (vertical: area ofmucosal lesion, horizontal: t-PA activity). The individual t-PA activity and damaged area were determined at 30 minutes after the injection of endothelin-1 50, 100, 250, and 500 pmollkg, each ofwhich consisted ofseven experiments. t-PA activity in the regional blood sample was significantly proportional to the area of lesion induced by endothelin-1 (r=0.877, p<0-001).
type plasminogen activator activity was significantly correlated with the mucosal lesion (r=0.877, p<000 1).
To investigate one of the mechanisms by which the tissue type plasminogen activator activity in regional blood increased, the platelet activating factor content of the gastric mucosa was measured before, five, and 30 minutes after the administration of endothelin-1 (500 pmol/kg). In the gastric mucosa before the endothelin-1 injection, platelet activating factor content was 28-0 (7-1) pmol/g frozen tissue (mean (SD) n=4). Platelet activating factor content increased five minutes after the administration of endothelin-1 (64.0 (114) n=4, p<O Ol) and decreased to 44.5 (11) at 30 minutes (p<0O05) (Fig 3) . Endothelin-1 in doses greater than 250 pmol/kg increased the platelet activating factor content at five minutes as compared with the control value (27.0 (6-1)) (Fig lC) .
The effects of the pretreatment with CV-6209 (0001, 0OOl, or 01 mg/kg), a selective platelet activating factor blocker, on both the mucosal injury and the tissue type plasminogen activator activation induced by endothelin-1 500 pmol/kg were tested. Figure 4A shows the effect of CV- from seven experiments. *p<0.05, **p<0.01 and ***p<0.001 as compared with the value ofendothelin-1 500 pmollkg.
6209 on the endothelin induced gastric mucosal injury. factor has also been shown to be a potent ulcerogen, inducing extensive gastric mucosal damage and haemorrhage associated with septic shock."' Sugatani et al recently determined the alteration ofthe platelet activating factor contents in rat gastric mucosa during water immersion stress and showed that endogenous platelet activating factor may actually be involved in the process of mucosal injury.6 The present study shows that endothelin-1 can increase the mucosal platelet activating factor content at five minutes after the administration in the rat stomach before the activation ofregional tissue type plasminogen activator. We have shown also that CV-6209, a platelet activating factor blocker, eliminated the tissue type plasminogen activator activation and mucosal lesion induced by endothelin-1. Although the detailed mechanism is unknown, our data raise the possibility that endothelin-I actually stimulates the production of platelet activating factor followed by the excessive release of tissue type plasminogen activator. These results are in accordance with the previous investigation that platelet activating factor activation directly increases the release of tissue type plasminogen activator from vessel walls in the experimental model of the isolated perfused rat hindlimb bed.'4 Taken together with the present results, platelet activating factor is likely to modulate regional fibrinolytic activity during gastric mucosal injury induced by endothelin-1.
